We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The Centers for Medicare & Medicaid Services (CMS) has tapped Linda Fishman
to head its Office of Legislation -- a move that brings her back to the agency
after a three-year absence.
Wyeth Pharmaceuticals is counting on strong demand for its vaccine Prevnar and
arthritis drug Enbrel to drive its first-quarter earnings above Wall Street's
expectations.
The FDA is seeking advice on whether it should consider reviewing
-- and possibly approving or clearing -- a new product labeled for use
in conjunction with an already approved product of a different type.
Klein-Becker USA, exclusive licensee of StriVectin-SD, the stretch-mark-cream-turned-anti-wrinkle-phenomenon,
has filed suit against Home Shopping Network, (HSN), Flageoli and Serious Skin
Care alleging they use false cost comparisons between a product called RuLinea-FX
and StriVectin-SD.
Dainippon Pharmaceutical and Kowa announced that they have concluded an agreement
on the upcoming transfer of Dainippon's over-the-counter (OTC) drug business
to Kowa.
Seattle law firm Keller Rohrback LLP has filed a securities fraud case in U.S.
District Court in Seattle against Cell Therapeutics Inc., a Seattle-based biotech
company.
Tanox has inked a deal with Miramar, Fla.-based Sunol Molecular Corp. to acquire
Sunol's tissue factor antagonist program for $6 million and Tanox stock shares.